🌍·20h agoIndustry
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
Publisher
A
Adial Pharmaceuticals
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Adial Pharmaceuticals
- Region
- 最新
- Scope
- Industry
- Published
- June 12, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on adial.com
Leave the platform to read the original full article on the publisher site.
Source: Adial Pharmaceuticals
Scope: Industry
Related coverage
More related coverage
Adial Pharmaceuticals·23h ago
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
Relmada Therapeutics·1d ago
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
eXoZymes·4d ago
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
AbbVie News·7h ago